Blog
RSS FeedPosted by Michael Wonder on 13 Aug 2019
Why America’s biggest charities are owned by pharmaceutical companies
13 August 2019 - Their generosity helps their bottom line. ...
Posted by Michael Wonder on 12 Aug 2019
Canadians are hopping mad about Trump’s drug importation plan. Some of them are trying to stop it.
12 August 2019 - Canadians are furious about the Trump administration’s plan to import their prescription drugs. And some of ...
Posted by Michael Wonder on 11 Aug 2019
Patient groups push back against Gilead's pricey HIV prevention treatment
7 August 2019 - Gilead Sciences hopes to soon introduce a pricey new pill to prevent HIV in people at risk ...
Posted by Michael Wonder on 07 Aug 2019
AMAG's female libido injectable therapy to sell at $899
7 August 2019 - AMAG Pharmaceuticals Inc’s treatment to boost sexual desire in premenopausal women will be offered at $899 ...
Posted by Michael Wonder on 01 Aug 2019
Trump administration weighs allowing drug imports for cheaper prescriptions
31 July 2019 - The proposal was announced between two Democratic debates, seemingly timed to show that President Trump was also ...
Posted by Michael Wonder on 26 Jul 2019
Breakthrough drugs raise worries over higher costs
25 July 2019 - Potential breakthroughs in medical treatment for serious diseases are turning what was once “the stuff of ...
Posted by Michael Wonder on 09 Jul 2019
Trump rule requiring drug prices in TV ads blocked
8 July 2019 - Federal judge sides with companies, saying regulation would violate free speech. ...
Posted by Michael Wonder on 04 Jul 2019
Karyopharm Therapeutics prices blood cancer treatment after FDA approval
4 July 2019 - Karyopharm Therapeutics has set a list-price for its blood cancer treatment Xpovio at $22,000 per month, ...
Posted by Michael Wonder on 03 Jul 2019
Some insurers are pushing back on the high price for a Novartis gene therapy
3 July 2019 - Barely a month after Novartis won U.S. regulatory approval for its gene therapy — the most ...
Posted by Michael Wonder on 11 Jun 2019
Jacobus prices its rare disease drug at half of what Catalyst charges, but will doctors prescribe it?
10 June 2019 - After weeks of anticipation, Jacobus Pharmaceutical, a small, family-run drug maker, has priced its rare disease ...
Posted by Michael Wonder on 10 Jun 2019
The $2.1 million question: what are the medical, ethical implications of the world's priciest drug?
10 June 2019 - With last month’s FDA approval, Zolgensma became the world’s most expensive medication. ...
Posted by Michael Wonder on 23 May 2019
Novartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range
23 May 2019 - Novartis AG’s top executive said on Wednesday it expects to price its gene therapy for spinal ...
Posted by Michael Wonder on 16 May 2019
Instalment payments could be used across gene therapy space, Spark CEO says
16 May 2019 - In a fireside chat at the recently concluded Veeva Summit in Philadelphia, Jeff Marrazzo said payment over ...
Posted by Michael Wonder on 15 May 2019
Drug prices in TV ads: how transparent are they?
15 May 2019 - A website launched by pharmaceutical giant Eli Lilly earlier this year leads with a daunting statement ...
Posted by Michael Wonder on 13 May 2019
Novartis pitches discounts on pricey gene therapy for deadly muscle disorder
11 May 2019 - Novartis is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal ...